Ondansetron
NDC 71335-0650, Ondansetron, tablet, orally disintegrating, from Bryant Ranch Prepack.
- Product NDC
- 71335-0650
- Status
- Listed
- Labeler
- Bryant Ranch Prepack
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090469
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71335-0650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ONDANSETRON4 mg/1
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71335-0650-0 | 71335065000 | 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-0) |
| 71335-0650-1 | 71335065001 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-1) |
| 71335-0650-2 | 71335065002 | 20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-2) |
| 71335-0650-3 | 71335065003 | 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-3) |
| 71335-0650-4 | 71335065004 | 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-4) |
| 71335-0650-5 | 71335065005 | 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-5) |
| 71335-0650-6 | 71335065006 | 9 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-6) |
| 71335-0650-7 | 71335065007 | 5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-7) |
| 71335-0650-8 | 71335065008 | 15 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-8) |
| 71335-0650-9 | 71335065009 | 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-0650-9) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e8d775b6-478c-499e-82be-bfdf006445e3
Use it
Look up 71335-0650 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71335-0650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71335-0650. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.